Announcements Trials
Browse Landscape

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Breast Neoplasms 92Neoplasms 87Lung Neoplasms 55Prostatic Neoplasms 48Colorectal Neoplasms 42Carcinoma, Non-Small-Cell Lung 35Pancreatic Neoplasms 24Multiple Myeloma 24Stomach Neoplasms 21Hematologic Neoplasms 21Carcinoma, Hepatocellular 19Ovarian Neoplasms 18Melanoma 17Lymphoma 16Leukemia, Myeloid, Acute 16Esophageal Neoplasms 16Brain Neoplasms 16Urinary Bladder Neoplasms 13Liver Neoplasms 13Colonic Neoplasms 13Uterine Cervical Neoplasms 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Neoplasm Metastasis 12Leukemia, Lymphocytic, Chronic, B-Cell 12Leukemia 12Kidney Neoplasms 12Head and Neck Neoplasms 12Endometrial Neoplasms 12Disease 12Recurrence 11

Interventions

Standard of Care 1Practice Guidelines as Topic 1Methods 1Interviews as Topic 1Educational Status 1Early Intervention, Educational 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Colitis, Ulcerative × 30 days × Clear all
NCT04751396 2026-05-20

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M.D. Anderson Cancer Center

Recruiting
125 enrolled
Dermatologic

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Lupus Erythematosus, Systemic, Melanoma, Psoriasis, Spondylitis, Ankylosing, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Arthritis, Reactive

NCT02808780 2026-05-08

OPAL

Janssen Biotech, Inc.

Active not recruiting
537 enrolled
Lymphoid

Colitis, Ulcerative, Lymphoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡